Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.62
+0.13 (1.74%)
Nov 21, 2024, 4:00 PM EST - Market closed
Kezar Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 56 | 69 | 481 | 822 | 242 | 77 | |
| Market Cap Growth | -34.78% | -85.69% | -41.42% | 240.23% | 214.65% | -82.98% | |
| Enterprise Value | -77 | -130 | 204 | 706 | 97 | -2 | |
| Last Close Price | 7.49 | 9.47 | 70.40 | 167.20 | 52.20 | 40.10 | |
| PS Ratio | - | 9.84 | - | - | - | - | |
| PB Ratio | 0.41 | 0.37 | 1.78 | 4.17 | 1.71 | 0.98 | |
| P/TBV Ratio | 0.42 | 0.37 | 1.78 | 4.17 | 1.71 | 0.98 | |
| Debt / Equity Ratio | 0.13 | 0.10 | 0.08 | 0.07 | 0.04 | 0.08 | |
| Asset Turnover | - | 0.03 | - | - | - | - | |
| Quick Ratio | 7.26 | 11.48 | 25.22 | 25.37 | 21.92 | 13.13 | |
| Current Ratio | 7.65 | 11.66 | 25.98 | 25.77 | 22.48 | 13.52 | |
| Return on Equity (ROE) | -54.72% | -44.54% | -29.24% | -32.34% | -38.12% | -37.56% | |
| Return on Assets (ROA) | -29.02% | -25.26% | -17.19% | -18.48% | -22.24% | -22.86% | |
| Return on Capital (ROIC) | -31.03% | -26.43% | -17.72% | -19.12% | -23.26% | -24.16% | |
| Earnings Yield | -175.03% | -147.92% | -14.18% | -6.65% | -17.28% | -45.71% | |
| FCF Yield | -139.59% | -121.18% | -12.55% | -5.20% | -15.38% | -39.71% | |
| Buyback Yield / Dilution | -0.55% | -7.70% | -27.69% | -19.90% | -130.58% | -85.92% | |
| Total Shareholder Return | -0.55% | -7.70% | -27.69% | -19.90% | -130.58% | -85.92% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.